logo

$5 And Under

Share SHARE

Microbot Medical Inc. (MBOT) announced Wednesday morning that it has been granted a Notice of Allowance from the U.S. Patent and Trademark Office for a patent for the prevention of shunt stenosis. Microbot Medical gapped open higher this morning and has risen sharply in early trade on the highest...

EyeGate Pharmaceuticals Inc. (EYEG) announced Tuesday morning that it has entered into an exclusive, worldwide licensing agreement with Valeant Pharmaceuticals International (VRX). EyeGate Pharmaceuticals gapped open higher Tuesday and climbed in early trade. Shares advanced further in the early...

EyeGate Pharmaceuticals Inc. (EYEG) announced Tuesday morning that it has entered into an exclusive, worldwide licensing agreement with Valeant Pharmaceuticals International (VRX). EyeGate Pharmaceuticals gapped open sharply higher Tuesday morning and has broken out further in the last few minutes...

Peregrine Pharmaceuticals Inc. (PPHM) has been climbing since the open of trade Friday on above average volume. Shares are now up 0.19 at $0.63. Peregrine Pharmaceuticals has been on an upward trend for the past 2 weeks and has surged to an 8 1/2 month high.

Novan Inc. (NOVN) has been climbing since the open of trade Wednesday and is now up 1.82 at $6.61. Trading volume has begun to accelerate in the last 15 minutes. Novan has broken out of a narrow range and has set over a 2-week high.

Evoke Pharma Inc. (EVOK) announced Wednesday morning that the FDA has exempted its Gimoti product from a Human Factors Validation study requirement prior to submission of a New Drug Application. Evoke Pharma has gapped open sharply higher this morning and is now up 1.46 at $4.07 on above average volume....

ZAIS Group Holdings (ZAIS) gapped up at the open Tuesday and has spiked higher in early trade. Shares are now up 1.55 at $3.60 on above average volume. ZAIS Group Holdings has surge to over a 6-month high.

Sky Solar Holdings (SKYS) reported third quarter EPS of $0.04 after the close Wednesday, compared to the loss of $0.01 a year ago. Sky Solar Holdings gapped open sharply higher Thursday and has jumped in early trade on above average volume. The stock is now up 1.59 at $3.39 and has surged to a 5-month high.

Aratana Therapeutics Inc. (PETX) announced Monday that it now expects to commercialize Entyce by late 2017, after the for Veterinary Medicine requested more information about the drug. Aratana Therapeutics gapped open lower Monday and fell during the first 45 minutes of trade, before settling into...

Galena Biopharma Inc. (GALE) announced Monday morning that the Data Safety Monitoring Board for its studies of NeuVax plus trastuzumab has recommended that both trials continue. Galena Biopharma has gapped open sharply higher this morning and is now up 0.74 at $1.94 on above average volume. The stock...

Pulmatrix Inc. (PULM) has been rising steadily since the open of trade Thursday and is now up 2.17 at $5.90 on above average volume. Pulmatrix is adding to yesterday's sharp gains and has surged to a new high for the year.

Catabasis Pharmaceuticals (CATB) announced Tuesday that the Part B of its MoveDMD trial of edasalonexent, for the treatment of Duchenne muscular dystrophy, did not meet the primary endpoint. Catabasis Pharmaceuticals gapped open dramatically lower Wednesday, but moved in a narrow range throughout...

Catabasis Pharmaceuticals (CATB) announced Tuesday that the Part B of its MoveDMD trial of edasalonexent, for the treatment of Duchenne muscular dystrophy, did not meet the primary endpoint. Catabasis Pharmaceuticals gapped open dramatically lower Wednesday morning and is now down 2.84 at $1.20 on...

Tenax Therapeutics Inc. (TENX) announced Tuesday morning that its Phase 3 LEVO-CTS trial did not achieve statistically significant reductions in the dual endpoints of the study. Tenax Therapeutics gapped open dramatically lower Tuesday, but moved in a narrow range throughout the session. The stock...

Tenax Therapeutics Inc. (TENX) announced Tuesday morning that its Phase 3 LEVO-CTS trial did not achieve statistically significant reductions in the dual endpoints of the study. Tenax Therapeutics gapped open dramatically lower Tuesday morning and is now down 1.43 at $0.51 on strong volume. The stock...

Follow RTT